Silvia Benito, Science Communication Manager, and Clara Vigo Xancó, Omnichannel Product Manager at Provital
ABSTRACT
Body sculpting is being redefined. Not by devices. Not by drainage. Not by another standard slimming strategy. But by longevity science.
In cosmetics, caloric restriction has recently been regarded as one of the most powerful biological strategies to enhance metabolic resilience, optimize mitochondrial function, and activate cellular recycling pathways. Today, this knowledge is stepping beyond skincare research and into bodycare — opening the door to a radically different way of addressing cellulite.
What if adipocytes could be guided to behave as if their energy were scarce? What if, instead of forcing fat breakdown, we could induce a metabolic shift that naturally prioritized lipid recycling, regulated inflammation, and oxidation, while supporting extracellular matrix integrity? By mimicking caloric restriction at the cellular level, adipose tissue can be reprogrammed — influencing not only fat storage, but the structural and biochemical architecture that underpins visible cellulite.
What makes this breakthrough particularly compelling is the scientific depth behind it. The article explores the innovative concept of dermohacking through the convergence of longevity science, multi-omic technologies, and traceable sourcing, illustrating how caloric restriction mimetics can be translated into targeted, evidence-based bodycare solutions that redefine the biological approach to cellulite and subcutaneous tissue optimisation.
The most interesting transformation currently happening in bodycare does not begin in the cosmetic lab – it begins in healthcare, longevity science, and consumer culture. Over the past few years, concepts such as caloric restriction, metabolic flexibility, and cellular optimisation have moved from academic research into mainstream awareness, largely driven by the rise of longevity-focused lifestyles and the popularisation of cellular caloric restriction interventions such as intermittent fasting and GLP-1 agonist therapies.
Drugs like GLP-1 receptor agonists, widely discussed for their role in metabolic regulation and weight management, have contributed to reshaping how consumers understand fat, energy balance, and body composition (1, 2, 3, 4). At the same time, but within a very different scope, the “biohacking” movement has normalised the idea that biological processes can be intentionally modulated to optimise performance, appearance, and long-term health.
Within this cultural context, beauty is increasingly interpreted as an extension of metabolic well-being, and bodycare in particular is being redefined accordingly. Consumers are no longer satisfied with surface-level promises. They are looking for products that resonate with the language of metabolic health, cellular renewal, and longevity. Caloric restriction – long studied for its ability to improve metabolic resilience, regulate mitochondrial function, and activate autophagy pathways – offers a new lens through which to understand adipose tissue functionality. These terms are no longer confined to scientific circles; they are part of an emerging beauty vocabulary that reflects a deeper, more systemic understanding of the body.
This is precisely where the concept of “dermohacking” – first introduced in 2023 in the context of advanced well-ageing skincare – finds a new and particularly relevant expression. Dermohacking was conceived as the topical translation of biohacking principles: using cosmetic actives to guide and optimise the skin’s own biological processes. Today, as longevity and metabolic health become central to consumer identity, extending this concept to bodycare – ‘dermohacking the body’ – feels not only natural, but necessary.
In this sense, caloric restriction mimetics in cosmetics are not just a scientific breakthrough; it is a cultural bridge. Applying caloric restriction to cosmetic bodycare translates the logic of dietary restriction and metabolic optimisation into a localised, cosmetic approach that fits seamlessly into a daily skin care routine. Instead of systemic interventions, it offers targeted modulation.
This conceptual shift is no longer theoretical. According to us innovation in cosmetic science does not happen at a single point in the development of an active ingredient. True innovation can emerge from multiple dimensions – from the origin of the raw material, to the technologies used to decode its activity, and to the way biological mechanisms are conceptualised and translated into cosmetic applications.
The integration of the latest advancements and a constant drive to bring new ideas to the industry allow all these elements to come together.
As an example of an innovative approach, a step-by-step overview of the scientific basis and research supporting the development of a new ingredient in the caloric restriction context is described. At the earliest stage, innovation began with sourcing. In our efforts to collaborate with local farmers, we identified apple blossoms—biochemical reservoirs of high-interest phytochemicals—as our raw material. Apple flowers are known to contain abundant polyphenols and flavonoids with antioxidant and bioactive properties relevant to human health – including cosmetic applications. Studying this underexplored material revealed a distinctive flavonoid profile with anti-inflammatory, antioxidant, and glucose transporter-modulating properties. This reinforces a broader principle: innovation does not necessarily require discovering a new botanical species; it can arise from identifying new molecular patterns and bioactivities within familiar plants. In this way, traceability and scientific curiosity become mutually reinforcing drivers of discovery.
The second dimension of innovation involved methodology. Traditional cosmetic efficacy studies often rely on single biomarkers. While informative, such approaches lack the resolution to disentangle complex cellular responses or to reveal deeper mechanistic insights. To overcome this limitation, we integrated transcriptomics and proteomics into our research framework. Multi-omic technologies enable the simultaneous evaluation of thousands of genes and proteins, providing a comprehensive view of how cells respond to an active stimulus at the molecular level and allowing reconstruction of pathways rather than isolated endpoints.
Applying this strategy to a human adipocyte model enabled us to move beyond surface-level activity to reconstruct a detailed map of modulated biological pathways. This advanced perspective is crucial for identifying mechanistic programs that are inaccessible to traditional assays. Notably, our multi-omic dataset revealed modulation of nutrient-sensing pathways and autophagy-related signalling cascades, which guided us toward deeper biological understanding of the active’s effects.
A key conceptual insight emerging from this analysis is the relevance of caloric restriction biology in the context of adipose tissue function. Caloric restriction, a well-studied intervention in biomedical and nutritional sciences, exerts beneficial effects on metabolic regulation, mitochondrial function, inflammation, and cellular stress responses across multiple tissues (5). Central to these effects is the regulation of the PI3K–Akt–mTOR signalling axis, a master integrator of nutrient availability, energy status, and autophagy. The modulation of this pathway forms a mechanistic basis for caloric restriction mimetics (CRMs), compounds that replicate biochemical features of low-energy states without actual calorie reduction.
While caloric restriction itself is not a cosmetic concept, its underlying mechanisms – particularly autophagy -have clear relevance when examined at the cellular level in skin. Autophagy, broadly described as a cellular recycling process, enables cells to degrade and reuse their components under conditions of energy scarcity or stress. In adipose cells, a specialised form of autophagy known as lipophagy targets lipid droplets for lysosomal degradation, effectively shifting the cell’s metabolic balance from lipid storage toward utilisation.
The identification of these pathways helps bridge longevity science with cosmetic efficacy, demonstrating that mechanisms once associated with metabolic health and ageing biology can be traced to measurable cellular effects relevant to skin and bodycare.
Taken together, this work underscores a broader vision for modern cosmetic innovation. True progress in this sector is multidimensional: it embraces sustainable and traceable sourcing, integrates advanced technologies, and frames biological activity in terms of pathways and new mechanisms rather than isolated outcomes. Using underexplored botanical biomass not only supports environmental responsibility but also expands the chemical space available for discovery. Multi-omic technologies provide the resolution needed to decode complex biological responses. And mechanistic frameworks derived from adjacent fields like ageing research enrich how we interpret and harness these responses.
Innovation in cosmetic science is not based on a single discovery; it is an iterative dialogue between raw material ingenuity, technological precision, and mechanistic understanding. By weaving these dimensions together, we can open new pathways for evidence-driven bodycare that are scientifically grounded, environmentally responsible, and biologically meaningful.
Moreover, for consumers already familiar with intermittent fasting or metabolic health strategies, this multi-dimensional narrative can be intuitive and compelling, as it aligns with a broader desire to take control of one’s biology in a measured, sustainable, and non-invasive way. Importantly, it also addresses one of the key tensions created by the rise of GLP-1 agonists and similar interventions: while these systemic approaches can deliver rapid body changes, they are often associated with concerns about skin quality, loss of firmness, or the so-called “Ozempic face” (6, 7). In contrast, localised cosmetic approaches inspired by caloric restriction on adipocytes offer a complementary pathway – one that supports tissue integrity, firmness, and structural balance precisely where it is applied.
Therefore, from a market perspective, this convergence of longevity science, biohacking culture, and bodycare innovation is accelerating the premiumization of the category. In our opinion, This evolution is also accompanied by a clear shift toward increasingly specialised anti-cellulite solutions, as consumers seek targeted, science-driven answers to one of the most prevalent aesthetic concerns. In fact, it is reported in the literature that “the well-known ‘orange peel skin’ affects an estimated 80–90% of women worldwide (8), yet its non-invasive treatment is still a challenge”.
In summary, this approach to “dermohacking the body” represents more than a new claim or positioning. It encapsulates a broader redefinition of what well-ageing bodycare means in a longevity-driven society. It suggests that cosmetic products can act as daily tools for biological optimisation – subtle, cumulative, and aligned with the body’s own regulatory systems. In this context, anti-cellulite care becomes a clear expression of body well-ageing: by addressing lipid recycling in adipocytes, improved extracellular matrix balance, and reducing oxidative stress and microinflammation, it reflects the same principles that underpin longevity-focused skincare.
Of course, the integration of longevity science into anti-cellulite cosmetics also raises important questions. What level of scientific evidence is necessary to support claims related to metabolic modulation? And how can brands communicate these mechanisms transparently without oversimplifying or overstating their impact? These challenges highlight the importance of robust research methodologies, interdisciplinary collaboration, and responsible science communication within the industry. As concepts such as caloric restriction and metabolic reprogramming enter cosmetic discourse, brands must support their claims with robust biological evidence and advanced analytical methods. Multi-omic approaches – integrating transcriptomics and proteomics – are increasingly essential for understanding the mechanism of action exerted by active ingredients through the complex network of signalling pathways involved in adipose tissue behaviour, inflammation, oxidative stress, and extracellular matrix dynamics. They allow researchers to move beyond single-marker claims and instead demonstrate coordinated biological effects across multiple pathways relevant to skin and adipose tissue health – the very factors that contribute to cellulite formation.
At the same time, the consumer is seeking not only efficacy but experience – a more holistic, sensorial, and results-driven approach to wellbeing that increasingly materialises in professional in-clinic and in-spa body treatments. These protocols combine mechanical or technological stimulation, expert application, and high-performance actives to deliver visible remodelling of the silhouette and skin quality. In this context, a new bodycare ingredient based on locally sourced botanicals would directly support this premium treatment narrative. By linking advanced longevity science with traceable sourcing, the natural and sustainable perception of ingredients integrate seamlessly into professional bodycare rituals that aim to deliver both immediate sensory experience and measurable long-term skin and body benefits.
This perspective opens up new opportunities for formulation, communication, and product development. It invites brands to create bodycare solutions that are modular, targeted, and integrated into broader wellness routines, while also enabling new synergies between cosmetics and the medical-aesthetics world – where topical products targeting subcutaneous caloric restriction can complement in-clinic or in-spa treatments.
As this research continues to unfold, concepts such as caloric restriction mimetics and dermohacking may well redefine the standards of efficacy and credibility in bodycare. In doing so, it invites both professionals and consumers to reconsider what is possible when cosmetic science engages more deeply with the biology of ageing, metabolism, and cellular resilience.
Dr Silvia Benito, Science Communication Manager, and Clara Vigo Xancó, Omnichannel Product Manager at Provital, will present “Pioneering Caloric Restriction Mimetics for Advanced Body Sculpting” at in-cosmetics Global on Tuesday, 14 April, 09:40–10:10 in Technical Seminar Theatre 2, Hall 7, Level 3 (Booth 3C130).
ABOUT THE AUTHORS
Silvia Benito holds a PhD in Cellular and Molecular Biology from the Curie Institute and PSL University in Paris. She investigated establishing innovative models to study skin pigmentation, collaborating with industrials. Now she develops scientific communication strategies in relation to global events, contributing to disseminate Provital’s scientific know-how and technologies.
Passionate about beauty innovation, Clara Vigo unites her technical background (Pharmacy, UB) with a global beauty development expertise gained through leading impactful ingredient launches and omnichannel initiatives. With an international dual master’s in cosmetic science and marketing (ISIPCA & UniPD), she bridges scientific insight and storytelling to drive industry-recognised results.
REFERENCES
- Yan XL, Pan YH, Fan RZ, Song QQ, Li S, Huang JL, et al. Discovery of the First Raptor (Regulatory-Associated Protein of mTOR) Inhibitor as a New Type of Antiadipogenic Agent. J Med Chem. 2023 Apr 27;66(8):5839–58. doi:10.1021/acs.jmedchem.3c00067
- Gong S, Li C, Leng Q, Liu C, Zhu Y, Zhang H, et al. Inhibition of the mTORC1 pathway alleviates adipose tissue fibrosis. Heliyon. 2023 Nov;9(11):e21526. doi:10.1016/j.heliyon.2023.e21526
- Cai H, Dong LQ, Liu F. Recent Advances in Adipose mTOR Signalling and Function: Therapeutic Prospects. Trends Pharmacol Sci. 2016 Apr;37(4):303–17. doi:10.1016/j.tips.2015.11.011
- Kim SG, Buel GR, Blenis J. Nutrient Regulation of the mTOR Complex 1 Signalling Pathway. Mol Cells. 2013 Jun;35(6):463–73. doi:10.1007/s10059-013-0138-2
- Yessenkyzy A, Saliev T, Zhanaliyeva M, Masoud AR, Umbayev B, Sergazy S, et al. Polyphenols as Caloric-Restriction mimetics and autophagy inducers in aging research. Nutrients. 2020 May 8;12(5):1344.
- Jansen LPNLODL. GLP-1s are boosting demand for medical aesthetics [Internet]. 2025 May [cited 2025 Sep 3]. Report.
- Sridhar D. Ozempic or Wegovy can be a godsend, but their non-medical use is alarming. The Guardian [Internet]. 2024 Jul 31 [cited 2025 Sep 3].
- A. Gabriel, V. Chan, M. Caldarella, T. Wayne, and E. O’Rorke, “Cellulite: Current Understanding and Treatment,” Aesthet. Surg. J. Open Forum, vol. 5, p. ojad050, Jan. 2023, doi: 10.1093/ASJOF/OJAD050.
